Abbott's second quarter sales were $12.6 billion, exceeding expectations.

Abbott's second quarter sales were $12.6 billion, higher than the IBES forecast of $12.5 billion; adjusted earnings per share for the second quarter were $1.31, above the IBES forecast of $1.28. Abbott expects sales to grow by 6.5% to 7.5% for the fiscal year; adjusted earnings per share are expected to be $5.45 to $5.60, while IBES estimates $5.49. Revenue for the 2026 fiscal year is projected to be $50.11 billion.